ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Small Cell Lung Carcinoma
Carcinoma
Colorectal Cancer
Squamous Cell Carcinoma of Head and Neck
Neoplasm Metastasis

Lung Cancer trials near Austin, TX, USA:

Locations recently updated

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

combination) vs durvalumab in limited-stage (LS)-small-cell lung cancer (SCLC) participants.The main goals of this study are to:* E...

Enrolling
Limited Stage Small Cell Lung Cancer
Drug: Durvalumab
Drug: BMS-986489

Phase 2

SCRI Development Innovations

Austin, Texas, United States and 25 other locations

This is a phase 3, open-label, 4-cohort study (3 randomized cohorts and 1 single-arm cohort). Participants enrolled in each cohort will be treated as...

Active, not recruiting
Non Small Cell Lung Cancer
Drug: NAI + Pembrolizumab + Carboplatin + Nab-paclitaxel or Paclitaxel
Drug: NAI + Nivolumab + Ipilimumab

Phase 3

ImmunityBio
ImmunityBio

Austin, Texas, United States and 30 other locations

the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...

Active, not recruiting
Lung Cancer
Drug: Itacitinib
Drug: Osimertinib

Phase 1, Phase 2

Incyte
Incyte

Austin, Texas, United States and 30 other locations

The goal of this platform clinical trial is to test how well novel treatment combinations work in participants with lung cancer. Su ...

Enrolling
Resectable Non-Small-Cell Lung Cancer
Lung Cancer
Drug: Paclitaxel
Drug: Carboplatin

Phase 2

Gilead Sciences
Gilead Sciences

Austin, Texas, United States and 94 other locations

treated NECTIN4-amplified advanced or metastatic non-small cell lung cancer (NSCLC) who have received at least one line of therapy ...

Enrolling
Non-Small Cell Lung Cancer
Drug: Zelenectide pevedotin (BT8009)

Phase 2

BicycleTx

Austin, Texas, United States and 6 other locations

This clinical trial is studying nonsquamous non-small cell lung cancer (NSCLC). Participants in this study must have cancer...

Active, not recruiting
Carcinoma, Non-Small-Cell Lung
Drug: sigvotatug vedotin
Drug: docetaxel

Phase 3

Seagen, a wholly owned subsidiary of Pfizer

Austin, Texas, United States and 334 other locations

This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Durvalumab
Procedure: Surgery

Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 230 other locations

The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the ...

Enrolling
Non-small Cell Lung Cancer
Drug: Nab-paclitaxel
Drug: Pembrolizumab

Phase 3

AstraZeneca
AstraZeneca

Round Rock, Texas, United States and 294 other locations

Non-small cell lung cancer (NSCLC) is a common type of lung cancer where abnormal cells in the lungs gro...

Enrolling
Non-Squamous Non-Small Cell Lung Cancer
Drug: Osimertinib (Osi)
Drug: Telisotuzumab Adizutecan

Phase 2, Phase 3

AbbVie
AbbVie

Austin, Texas, United States and 29 other locations

This is a Phase II, Open Label, Multicenter, Single Arm Study of WSD0922-FU for Patients with Locally Advanced or Metastatic Non-Small Cell Lung...

Enrolling
Non Small Cell Lung Cancer
Drug: WSD0922-FU Tablets, Dose level A
Drug: WSD0922-FU Tablets, Dose level B

Phase 2

Wayshine Biopharm, Inc.

Austin, Texas, United States and 17 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems